Chidamide Combined With Cisplatin for Relapsed or Metastatic Triple-negative Breast Cancer

Clinical trial NCT04192903 · UNKNOWN

Trial details

NCT number: NCT04192903
Sponsor: Fudan University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Triple-negative Breast Cancer

Start date: 2019-12-25
Primary completion: 2022-06-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.